Literature DB >> 20643813

LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?

Selinda J Orr1, Daniel W McVicar.   

Abstract

LAB/NTAL/Lat2 is a transmembrane adaptor protein closely related to LAT. It is expressed in various myeloid and lymphoid cells, many of which also express LAT. Phosphorylation of LAB occurs following engagement of various ITAM- and non-ITAM-linked receptors and can play positive and negative roles following receptor engagement. LAT binds PLCγ directly, resulting in efficient Ca²+ flux and degranulation. However, LAB does not contain a PLCγ-binding motif and only binds PLCγ indirectly, possibly via Grb2, thereby resulting in suboptimal signaling. As LAT can signal more efficiently than LAB, competition between the 2 for space/substrates in the lipid rafts can attenuate signaling. This competition model requires coexpression of LAT; however, LAB is repressive, even in cells lacking substantial LAT expression such as macrophages and mature B cells. The reported interaction between LAB and the ubiquitin E3-ligase c-Cbl suggests 1 possible mechanism for LAT-independent inhibition by LAB, but such a model requires further investigation. Given the wide-reaching expression pattern of LAB, LAB has the ability to modulate signaling in virtually every type of leukocyte. Regardless of its ultimate mode of action, the potent regulatory capability of LAB proves this protein to be a complex adaptor that warrants continued, substantial scrutiny by biochemists and immunologists alike.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643813      PMCID: PMC3004523          DOI: 10.1189/jlb.0410221

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  52 in total

1.  LAB: a new membrane-associated adaptor molecule in B cell activation.

Authors:  Erin Janssen; Minghua Zhu; Weijia Zhang; Surapong Koonpaew; Weiguo Zhang
Journal:  Nat Immunol       Date:  2003-01-06       Impact factor: 25.606

Review 2.  Transmembrane adaptor proteins in membrane microdomains: important regulators of immunoreceptor signaling.

Authors:  Václav Horejsí
Journal:  Immunol Lett       Date:  2004-03-29       Impact factor: 3.685

3.  The importance of three membrane-distal tyrosines in the adaptor protein NTAL/LAB.

Authors:  Surapong Koonpaew; Erin Janssen; Minghua Zhu; Weiguo Zhang
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

4.  LAT links the pre-BCR to calcium signaling.

Authors:  Yu-wen Su; Hassan Jumaa
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

5.  Exploring Williams-Beuren syndrome using myGrid.

Authors:  R D Stevens; H J Tipney; C J Wroe; T M Oinn; M Senger; P W Lord; C A Goble; A Brass; M Tassabehji
Journal:  Bioinformatics       Date:  2004-08-04       Impact factor: 6.937

6.  NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation.

Authors:  Christine Tkaczyk; Vaclav Horejsi; Shoko Iwaki; Petr Draber; Lawrence E Samelson; Anne B Satterthwaite; Dong-Ho Nahm; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Blood       Date:  2004-03-09       Impact factor: 22.113

7.  Linker for activation of B cells: a functional equivalent of a mutant linker for activation of T cells deficient in phospholipase C-gamma1 binding.

Authors:  Erin Janssen; Minghua Zhu; Brandon Craven; Weiguo Zhang
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

Review 8.  The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis.

Authors:  P Besmer; K Manova; R Duttlinger; E J Huang; A Packer; C Gyssler; R F Bachvarova
Journal:  Dev Suppl       Date:  1993

9.  Positive and negative regulation of FcepsilonRI-mediated signaling by the adaptor protein LAB/NTAL.

Authors:  Minghua Zhu; Yan Liu; Surapong Koonpaew; Olivia Granillo; Weiguo Zhang
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

10.  Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL.

Authors:  Petra Volná; Pavel Lebduska; Lubica Dráberová; Sárka Símová; Petr Heneberg; Michael Boubelík; Viktor Bugajev; Bernard Malissen; Bridget S Wilson; Václav Horejsí; Marie Malissen; Petr Dráber
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more
  10 in total

1.  The AML1/ETO target gene LAT2 interferes with differentiation of normal hematopoietic precursor cells.

Authors:  Aitomi Essig; Jesus Duque-Afonso; Sven Schwemmers; Heike L Pahl; Michael Lübbert
Journal:  Leuk Res       Date:  2013-12-25       Impact factor: 3.156

Review 2.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

Review 3.  Emerging roles for protein S-palmitoylation in immunity from chemical proteomics.

Authors:  Jacob S Yount; Mingzi M Zhang; Howard C Hang
Journal:  Curr Opin Chem Biol       Date:  2013-01-14       Impact factor: 8.822

4.  Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity.

Authors:  Carolina H Thomé; Guilherme A dos Santos; Germano A Ferreira; Priscila S Scheucher; Clarice Izumi; Andreia M Leopoldino; Ana Maria Simão; Pietro Ciancaglini; Kleber T de Oliveira; Alice Chin; Samir M Hanash; Roberto P Falcão; Eduardo M Rego; Lewis J Greene; Vitor M Faça
Journal:  Mol Cell Proteomics       Date:  2012-09-22       Impact factor: 5.911

Review 5.  Triggering receptor expressed on myeloid cells and 5'adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target.

Authors:  Finosh G Thankam; Matthew F Dilisio; Kaitlin A Dougherty; Nicholas E Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-06-13       Impact factor: 4.473

6.  Survey of activated FLT3 signaling in leukemia.

Authors:  Ting-lei Gu; Julie Nardone; Yi Wang; Marc Loriaux; Judit Villén; Sean Beausoleil; Meghan Tucker; Jon Kornhauser; Jianmin Ren; Joan MacNeill; Steven P Gygi; Brian J Druker; Michael C Heinrich; John Rush; Roberto D Polakiewicz
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

7.  Multiple regulatory roles of the mouse transmembrane adaptor protein NTAL in gene transcription and mast cell physiology.

Authors:  Iva Polakovicova; Lubica Draberova; Michal Simicek; Petr Draber
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

8.  Tespa1 negatively regulates FcεRI-mediated signaling and the mast cell-mediated allergic response.

Authors:  Di Wang; Mingzhu Zheng; Yuanjun Qiu; Chuansheng Guo; Jian Ji; Lei Lei; Xue Zhang; Jingjing Liang; Jun Lou; Wei Huang; Bowen Dong; Songquan Wu; Jianli Wang; Yuehai Ke; Xuetao Cao; Yi Ting Zhou; Linrong Lu
Journal:  J Exp Med       Date:  2014-11-24       Impact factor: 14.307

9.  NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.

Authors:  Carolina Hassibe Thomé; Germano Aguiar Ferreira; Diego Antonio Pereira-Martins; Vitor Marcel Faça; Eduardo M Rego; Guilherme Augusto Dos Santos; César Alexander Ortiz; Lucas Eduardo Botelho de Souza; Lays Martins Sobral; Cleide Lúcia Araújo Silva; Priscila Santos Scheucher; Cristiane Damas Gil; Andréia Machado Leopoldino; Douglas R A Silveira; Juan L Coelho-Silva; Fabíola Traina; Luisa C Koury; Raul A M Melo; Rosane Bittencourt; Katia Pagnano; Ricardo Pasquini; Elenaide C Nunes; Evandro M Fagundes; Ana Beatriz F Gloria; Fábio Rodrigues Kerbauy; Maria de Lourdes Chauffaille; Armand Keating; Martin S Tallman; Raul C Ribeiro; Richard Dillon; Arnold Ganser; Bob Löwenberg; Peter Valk; Francesco Lo-Coco; Miguel A Sanz; Nancy Berliner
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

10.  LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells.

Authors:  Selinda J Orr; Ashley R Burg; Tim Chan; Laura Quigley; Gareth W Jones; Jill W Ford; Deborah Hodge; Catherine Razzook; Joseph Sarhan; Yava L Jones; Gillian C Whittaker; Kimberly C Boelte; Lyudmila Lyakh; Marco Cardone; Geraldine M O'Connor; Cuiyan Tan; Hongchuan Li; Stephen K Anderson; Simon A Jones; Weiguo Zhang; Philip R Taylor; Giorgio Trinchieri; Daniel W McVicar
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.